Moneycontrol PRO
HomeNewsBusinessPankaj Patel steps down as Cadila MD, son Sharvil to take over

Pankaj Patel steps down as Cadila MD, son Sharvil to take over

The Board of Directors of Cadila Healthcare has unanimously approved the appointment of Sharvil P Patel as the Manging Director of the company, Cadila Healthcare said in a filing to BSE.

July 13, 2017 / 08:49 IST
Aurobindo Pharma Ltd.
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    Drug firm Cadila Healthcare said its chairman and MD Pankaj R Patel has stepped down as Managing Director of the company.

    His son Sharvil P Patel, who is Joint Managing Director, will take over as the new MD as part of succession planning, according to a regulatory filing by Cadila Healthcare.

    The Board of Directors of Cadila Healthcare has unanimously approved the appointment of Sharvil P Patel as the Manging Director of the company, Cadila Healthcare said in a filing to BSE.

    Commenting on the development, Pankaj R Patel said: "...We at Zydus have been working on our succession planning programme over the last decade. In line with this and also to ensure the continuity of business going forward, Dr Sharvil Patel has been appointed as the Managing Director".

    He has been associated with the company for close to two decades and has been actively associated in managing the business for over a decade, he added.

    first published: Jul 13, 2017 08:28 am

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347